Research progress of cellular immunotherapy for hematological malignancies
10.11904/j.issn.1002-3070.2016.01.013
- VernacularTitle:血液系统恶性肿瘤细胞免疫治疗的研究进展
- Author:
Juanjuan HUANG
;
Wenxin WANG
- Publication Type:Journal Article
- Keywords:
Hematological malignancies;
Cellular immunotherapy;
CIK cells;
NK cells;
CART
- From:
Practical Oncology Journal
2016;30(1):61-65
- CountryChina
- Language:Chinese
-
Abstract:
In recent years,considerable progress has been made in the treatment of hematologic malig-nancies.However,most patients will eventually relapse and suffer from severe side effects caused by chemotherapy or radiation.Thus,as a well tolerated,safe,effective and innovative therapy,adoptive cellular immunotherapy e-merges at this very moment.This therapy can kill tumors or control recurrence by reinfusing the in vitro amplifi-cated or treated immune effective cells into the patients.It has been actively used in the treatment of various he-matological malignancies and achieved significant effects,which brings hope for more and more patients with re-lapsed or refractory hematological diseases.
